Macroview Investment Management LLC Novo Nordisk A S Transaction History

Macroview Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$122.71 - $146.91 $2,822 - $3,378	-23 Reduced 38.33%	37 $5,000
Q4 2023 Jan 30, 2024	SELL	$87.78 - $105.45 $5,266 - $6,327	-60 Reduced 50.0%	60 $6,000
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $8,184 - $17,958	90 Added 300.0%	120 $10,000
Q2 2023 Jul 13, 2023	BUY	$155.98 - $172.65 $4,679 - $5,179	30 New	30 $4,000

1,882

336M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.